Revelation Biosciences, Inc. (REVB)

NASDAQ: REVB · IEX Real-Time Price · USD

1.790

-0.080 (-4.28%)

At close: Jul 2, 2024, 4:00 PM

1.761

-0.029 (-1.62%)

After-hours: Jul 2, 2024, 4:28 PM EDT

Revelation Biosciences Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020
Net Income	-0.12	-10.83	-11.99	-1.63
Depreciation & Amortization	0.03	0.04	0.07	0
Share-Based Compensation	0.16	0.3	0.47	0.03
Other Operating Activities	-7.35	-0.73	0.36	0.18
Operating Cash Flow	-7.29	-11.22	-11.09	-1.42
Capital Expenditures	0	0	-0.13	0
Investing Cash Flow	0	0	-0.13	0
Share Issuance / Repurchase	14.03	15.98	0.6	5.51
Debt Issued / Paid	0	-0.8	0	0
Other Financing Activities	-0	0.01	7.4	0.4
Financing Cash Flow	14.03	15.2	8	5.91
Net Cash Flow	6.74	3.98	-3.22	4.49
Free Cash Flow	-7.29	-11.22	-11.22	-1.42
Free Cash Flow Per Share	-31.87	-154.57	-1193.74	-618.88

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).